e-learning
resources
Amsterdam 2011
Monday, 26.09.2011
COPD: burden of disease, imaging and management
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Costs of COPD by disease severity
S. A. Jansson, H. Backman, A. Stenling, A. Lindberg, E. Rönmark, B. Lundbäck (Luleå, Södertälje, Umeå, Gothenburg, Sweden)
Source:
Annual Congress 2011 - COPD: burden of disease, imaging and management
Session:
COPD: burden of disease, imaging and management
Session type:
Oral Presentation
Number:
2957
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
S. A. Jansson, H. Backman, A. Stenling, A. Lindberg, E. Rönmark, B. Lundbäck (Luleå, Södertälje, Umeå, Gothenburg, Sweden). Costs of COPD by disease severity. Eur Respir J 2011; 38: Suppl. 55, 2957
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Evidence-based eHealth for COPD
Related content which might interest you:
Are COPD exacerbations associated with the severity of the disease?
Source: Eur Respir J 2005; 26: Suppl. 49, 300s
Year: 2005
Impact of comorbidities on chronic obstructive pulmonary disease (COPD) exacerbations in Singapore
Source: International Congress 2015 – Clinical assessment in asthma and COPD
Year: 2015
Costs of exacerbations in COPD
Source: Annual Congress 2012 - Healthcare utilisation and treatment of asthma and COPD
Year: 2012
Clinical characteristics and health burden of patients with chronic obstructive pulmonary disease exacerbation
Source: International Congress 2015 – Patient health gains related to the economic effectiveness of disease management programmes
Year: 2015
Predictors of coronary heart disease in patients with COPD
Source: International Congress 2015 – COPD: chronic disease and comorbidities
Year: 2015
The relation of comorbidities with the exacerbation severity in patients with COPD
Source: Annual Congress 2013 –COPD mechanisms
Year: 2013
The CANT score: Predicting mortality in exacerbations of chronic obstructive pulmonary disease
Source: International Congress 2016 – Highlights in the management of COPD and beyond
Year: 2016
Predictors of readmission after hospitalization for acute exacerbations of chronic obstructive pulmonary disease (AECOPD)
Source: Annual Congress 2013 –COPD: markers and inflammation
Year: 2013
Impact of not planned readmissions due to acute exacerbations of chronic obstructive pulmonary disease
Source: International Congress 2015 – Notable abstracts in exacerbations, mechanisms and biomarkers in COPD
Year: 2015
Factors affecting in-hospital mortality in patients with chronic obstructive pulmonary disease exacerbation
Source: Annual Congress 2013 –The latest insights in chronic care
Year: 2013
Outcome of patients following hospitalization with acute exacerbation of chronic obstructive pulmonary disease (AECOPD) , with and without cardiovascular risk factors
Source: International Congress 2016 – Novel avenues in the treatment of COPD I
Year: 2016
Relationship between pharmacotherapy and severity of disease in patients with COPD
Source: Eur Respir J 2007; 30: Suppl. 51, 73s
Year: 2007
Trends in healthcare utilization and costs prior to a chronic obstructive pulmonary disease (COPD) diagnosis
Source: Eur Respir J 2006; 28: Suppl. 50, 36s
Year: 2006
Care of COPD patients with anxiety after hospitalization with an exacerbation of chronic obstructive pulmonary disease (COPD). A pilot study
Source: Annual Congress 2010 - Optimising the care and management of patients with COPD
Year: 2010
Early readmission after hospitalization for acute exacerbations of chronic obstructive pulmonary disease (AECOPD) is associated with high mortality
Source: Annual Congress 2013 –COPD diagnosis
Year: 2013
Assessment of treatment efficiency in patients with chronic obstructive pulmonary disease combined with gastroesophageal reflux disease during treatment with melatonin
Source: International Congress 2014 – Clinical presentations
Year: 2014
Impact of cardiovascular comorbidities on COPD exacerbations
Source: Annual Congress 2007 - COPD and comorbidity
Year: 2007
Comorbit coronary artery disease is related to worse outcomes in patients hospitalised for COPD exacerbation
Source: International Congress 2016 – Exploring mechanisms in health and disease
Year: 2016
Exacerbations of chronic obstructive pulmonary disease (COPD): Correlation of hospitalization days with epidemiological and clinical parameters
Source: Annual Congress 2010 - COPD: treatment and monitoring
Year: 2010
COPD mortality - Is it all COPD?
Source: International Congress 2015 – Clinical assessment and monitoring of asthma and COPD
Year: 2015
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept